Recent Landmark Drug Trials in Heart Failure Management

Volume 2, Jan 2013

Gagandeep Singh Wander MD, Manish Bansal MD, DNB, Gurgaon, India

More than a decade and several thousands of procedures Heart failure (both acute as well as chronic) is a common and serious health problem. Even with existing treatment, which has substantially improved outcomes, prognosis is fairly poor. Standard pharmacological treatment includes diuretics, β-blockers and renin–angiotensin aldosterone system (RAAS) antagonists. Development of newer therapeutic approaches for the treatment of this disorder is essential. We discuss here few recent drug trials with the potential to change management of heart failure favorably.

Volume 2, Number 1, Pages: 58-9